Text Size

Multiple Sclerosis Rehabilitation Study

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Melbourne Health.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Melbourne Health
ClinicalTrials.gov Identifier:
NCT00202254
First received: September 12, 2005
Last updated: October 3, 2006
Last verified: September 2005
History of Changes
  Purpose

The effects of routine rehabilitation in MS patients versus no rehabilitation.


Condition Intervention
Multiple Sclerosis
 Behavioral: Physiotherapy
Behavioral: Occupational therapy
Behavioral: Speech pathology

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: 'Functioning and Disability' and 'Quality of Life' in an Australian Community Cohort With Multiple Sclerosis.

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Melbourne Health:

Primary Outcome Measures:
  • Improvement in fatigue levels and psychological well being (depression, stress and anxiety) in MS patients. Outcome will be measured at 13 months since recruitment.

Secondary Outcome Measures:
  • - Improvement in function and activities of daily living ie. disability- Quality of life.- Carer Burder in multiple sclerosis.- Utilisation of health services.- 13 months follow up.

Estimated Enrollment: 100
Study Start Date: December 2004
Detailed Description:

Routine rehabilitation inervention in patients with MS. This comprises of medical and nursing input, physiotherapy, occupational therapy, speech pathology, neuropsychology, compared with a "control" group on the waiting list for rehabilitation intervention. Duration of intervention is 6 weeks.

  Eligibility

Ages Eligible for Study:   19 Years to 64 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Confirmed diagnosis of MS (Paty)- Community dwelling participants with known neurological and psychological deficits per EDSS groups.- Age 19-64 years.- Male and female participants.- Residing within 60kms of metropolitan Melbourne.- Have mobility problem.- Adequate cognition (KFS=2).

Exclusion Criteria:

  • Patients residing in nursing home and other residential care.- Those with severe cognitive problems KFS>2.-
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00202254

Sponsors and Collaborators
Melbourne Health
Investigators
Principal Investigator: Fary Khan Melbourne Extended Care Rehabilitation Service
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00202254     History of Changes
Other Study ID Numbers: HREC 2004.101, MelbUni HREC 040334
Study First Received: September 12, 2005
Last Updated: October 3, 2006
Health Authority: Australia: Human Research Ethics Committee

Keywords provided by Melbourne Health:
Mulitple Sclerosis
MS

Additional relevant MeSH terms:
Multiple Sclerosis
Sclerosis
Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System
Nervous System Diseases
 Demyelinating Diseases
Autoimmune Diseases
Immune System Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on May 23, 2013